Clinical Trial Update: Intralesional Versus Intramuscular Methotrexate for Non-melanoma Skin Cancers [Phase 2]

View source ↗

Summary

A Phase 2 trial comparing intralesional versus intramuscular methotrexate for non-melanoma skin cancers has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Non-melanoma Skin Cancer

Drugs mentioned

• METHOTREXATE (METHOTREXATE)

Snippet

Sponsor: Zagazig University | Conditions: Non-melanoma Skin Cancers | Phase 2 | Status: COMPLETED